|1.||Kodera, Yasuhiro: 2 articles (05/2015 - 01/2014)|
|2.||Shimizu, Dai: 2 articles (05/2015 - 01/2014)|
|3.||Yamada, Suguru: 2 articles (05/2015 - 01/2014)|
|4.||Nakayama, Goro: 2 articles (05/2015 - 01/2014)|
|5.||Koike, Masahiko: 2 articles (05/2015 - 01/2014)|
|6.||Hibino, Soki: 2 articles (05/2015 - 01/2014)|
|7.||Fujiwara, Michitaka: 2 articles (05/2015 - 01/2014)|
|8.||Oya, Hisaharu: 2 articles (05/2015 - 01/2014)|
|9.||Nomoto, Shuji: 2 articles (05/2015 - 01/2014)|
|10.||Sugimoto, Hiroyuki: 2 articles (05/2015 - 01/2014)|
|1.||Schizophrenia (Dementia Praecox)
07/01/2010 - "A two-stage case-control association study of the dihydropyrimidinase-like 2 gene (DPYSL2) with schizophrenia in Japanese subjects."
12/01/2006 - "An investigation of the dihydropyrimidinase-like 2 (DPYSL2) gene in schizophrenia: genetic association study and expression analysis."
04/01/2003 - "In addition, the DRP-2 gene (Dihydropyrimidinase-like 2; DPYSL2) is located on chromosome 8p21, a region that has been implicated in schizophrenia in genetic linkage studies. "
07/01/2010 - "We examined the association of schizophrenia (SCZ) and dihydropyrimidinase-like 2 (DPYSL2), also known as collapsin response mediator protein 2, which regulates axonal growth and branching. "
10/01/2010 - "We used two-dimensional gel electrophoresis combined with mass spectrometry, the most traditional approach to studying the proteome, to reveal the differentially expressed proteins in schizophrenia, and western blot to validate some interesting potential biomarker candidates such as dihydropyrimidinase-like 2 and alpha-crystallin, involved in a number of processes such as cytoskeleton arrangement. "
|2.||Brain Neoplasms (Brain Tumor)
|3.||Astrocytoma (Pilocytic Astrocytoma)
01/01/2014 - "Dihydropyrimidinase-like 3 (DPYSL3) is a cell adhesion molecule that has been reported to be involved in the metastatic process of tumor cells. "
04/01/2011 - "Identification of dihydropyrimidinase-related protein 4 as a novel target of the p53 tumor suppressor in the apoptotic response to DNA damage."
03/01/2010 - "Contribution of dihydropyrimidinase gene alterations to the development of serious toxicity in fluoropyrimidine-treated cancer patients."
04/01/2004 - "Gene expression analysis comparing 15 microdissected OSCC with 16 normal epithelium samples revealed overexpression specific to LRP12 but not the neighboring genes, dihydropyrimidinase and FOG2, suggesting that LRP12 may function as an oncogene in oral tumors."
11/01/1985 - "Dihydropyrimidinase, on the other hand, is highly active in all solid tumors studied but not in their normal counterparts; therefore, we suggest that dihydropyrimidinase can serve as a good marker of tumorigenicity as well as a target for cancer chemotherapy of human solid tumors."
|5.||Dihydropyrimidine Dehydrogenase Deficiency
06/01/2013 - "Dihydropyrimidinase deficiency is an autosomal recessive inborn error of metabolism characterised by the presence of dihydropyrimidinuria. "
06/01/2013 - "Diagnosis of dihydropyrimidinase deficiency in a Chinese boy with dihydropyrimidinuria."
01/01/2012 - "Dihydropyrimidinase deficiency: the first feline case of dihydropyrimidinuria with clinical and molecular findings."
07/15/2003 - "Rapid gas chromatographic-mass spectrometric diagnosis of dihydropyrimidine dehydrogenase deficiency and dihydropyrimidinase deficiency."
09/01/1998 - "Dihydropyrimidinase (DHP) deficiency (MIM 222748) is characterized by dihydropyrimidinuria and is associated with a variable clinical phenotype. "
|1.||Proteins (Proteins, Gene)
|3.||Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)
|4.||Staphylococcal Protein A (A, Protein)
|7.||Dopamine and cAMP-Regulated Phosphoprotein 32
|8.||Qa-SNARE Proteins (Syntaxin)
|9.||14-3-3 Proteins (14-3-3 Protein)
|1.||Drug Therapy (Chemotherapy)